Literature DB >> 15235693

Extrapulmonary tuberculosis, clinical presentation and outcome.

Zakeya A Bukhary1, Abdulrahman A Alrajhi.   

Abstract

OBJECTIVE: To identify patterns, features, and outcome of extrapulmonary tuberculosis in a tertiary care setting.
METHODS: A retrospective case-series was carried out of all cases diagnosed and treated as extrapulmonary tuberculosis during 1991 through to 2000 at King Faisal Specialist Hospital and Research Centre (KFSH and RC), Riyadh, Kingdom of Saudi Arabia. Demographic, clinical, laboratory, and outcome data were abstracted from medical records.
RESULTS: Over a 10-year period, 394 cases of extrapulmonary tuberculosis were diagnosed and treated at KFSH and RC. Isolated extrapulmonary tuberculosis was identified in 339 (86%) patients, 55 cases (14%) had both pulmonary and extrapulmonary tuberculosis. Mean age was 45-years, and 188 patients (47%) had co-morbidities, most commonly diabetes mellitus in 14.2% of patients. Laboratory confirmation of extrapulmonary tuberculosis was available on 386 patients. The most frequent site involvement was lymphadenopathy in 41% of the time. Chest x-ray was normal in 75% of patients. Among 298 patients with follow up data, 10 (3.4%) had documented relapse and 50 (16%) died. Death was related to tuberculosis in 24 (48%) patients.
CONCLUSION: A high level of clinical suspicion is essential for early diagnosis and treatment of extrapulmonary tuberculosis to reduce the significant morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15235693

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  8 in total

1.  Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Authors:  Sahal Al-Hajoj; Bright Varghese; Mohammed M Shoukri; Ruba Al-Omari; Mais Al-Herbwai; Fahad Alrabiah; Abdulrahman A Alrajhi; Naila Abuljadayel; Sahar Al-Thawadi; Alimuddin Zumla; Matteo Zignol; Mario C Raviglione; Ziad Memish
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

2.  Morbidity patterns among king faisal university students, Al hassa, kingdom of saudi arabia.

Authors:  Abdulrashid C Choudary; Ali I Al-Sultan; Tarek T Tawfik
Journal:  J Family Community Med       Date:  2007-01

3.  Exploring the sociodemographic and clinical features of extrapulmonary tuberculosis in Saudi Arabia.

Authors:  Sahal Al-Hajoj; Mohammed Shoukri; Ziad Memish; Raafat AlHakeem; Fahad AlRabiah; Bright Varghese
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

Review 4.  Diabetes-related tuberculosis in the Middle East: an urgent need for regional research.

Authors:  Yosra M Alkabab; Hail M Al-Abdely; Scott K Heysell
Journal:  Int J Infect Dis       Date:  2015-09-25       Impact factor: 3.623

5.  Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia.

Authors:  Mogahid M Elhassan; Hassan A Hemeg; Miskelyemen A Elmekki; Khalid A Turkistani; Ahmed A Abdul-Aziz
Journal:  Infect Disord Drug Targets       Date:  2017

6.  Evaluation of modified bleach technique for the detection of acid fast bacilli in lymph node aspirate at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.

Authors:  Firehiwot Mulugeta; Moges Tiruneh; Bewketu Abebe; Gashaw Yitayew; Zimam Ayehubizu; Muluwork Getahun; Aschalew Gelaw
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-08-05

Review 7.  Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: a review.

Authors:  Tarik A Elhadd; Abdallah A Al-Amoudi; Ali S Alzahrani
Journal:  Ann Saudi Med       Date:  2007 Jul-Aug       Impact factor: 1.526

8.  Tuberculosis treatment outcome in a tertiary care setting.

Authors:  Zakeya A Bukhary; Abdulrahman A Alrajhi
Journal:  Ann Saudi Med       Date:  2007 May-Jun       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.